We believe that the superiority of TL-PSMA compared with PSMA-TV (which only accounts for MTV) is a direct result of the fact that TL-PSMA also considers the degree of PSMA expression in the tumor, and therefore, it facilitates the integration of the molecular profile of PCa in risk stratification. The gene discussed is FOLH1; the disease is posterior cortical atrophy.